Mass Spectrometry Market Overview, Segment Analysis, Development and Demand Forecast to 2030

The mass spectrometry market is predicted to advance at a 6.4% CAGR from 2021 to 2030, hitting $7,492.1 million in 2030. The major reasons behind the growth of this market are the increasing expenditure in the healthcare sector and technological enhancement in MS.

The pharmaceuticals category is expected to grow the fastest, by around 8%, in the end user segment over this decade. MS has been a leading technology in pharmaceutical analysis for a while, as it caters to both quantitative and qualitative studies.

Browse full report at: https://www.psmarketresearch.com/market-analysis/mass-spectrometry-market

Moreover, the demand for MS equipment is growing at an extensive pace, mainly because of the rapid development of new applications. Apart from this, instrumentation is being innovated to keep up with the growing demand for sensitivity and throughput, because of the tightening of the regulatory requirements.

In 2021, the drug discovery and development category had the largest MS market share, of more than 40%. Mass spectroscopy is majorly used in drug discovery and development as it facilitates in understanding the structure of drugs. Additionally, it is used in the comprehensive and quantitative analysis of a wide range of metabolites in biological samples.

Furthermore, the usage of several ionization methods in MS, such as electrospray and matrix-assisted laser desorption electrospray, helps in the analysis of a wide range of biomolecules, such as lipids, sugars, and peptides.

Major players operating in the mass spectrometry market include Thermo Fisher Scientific Inc., AB Sciex Pte Ltd., Agilent Technologies Inc., Waters Corporation, PerkinElmer Inc., Shimadzu Corporation, Bruker Corporation, JEOL Ltd., and LECO Corporation.

Make inquiry before purchase of this report: https://www.psmarketresearch.com/send-enquiry?enquiry-url=mass-spectrometry-market

Mass Spectrometry Industry Report Coverage
Market Segmentation by Technology
• Hybrid
• Single
• Others
Market Segmentation by Application
• Drug Discovery and Development
• Proteomics
• Clinical Testing
• Others
Market Segmentation by End User
• Pharmaceuticals
• Life Sciences and Biotechnology
• Academic and Research Institutes
• Hospitals
• Others
Market Segmentation by Region
• North America Mass Spectrometry Market
o By technology
o By application
o By end user
o By country - U.S. and Canada
• Europe Mass Spectrometry Market
o By technology
o By application
o By end user
o By country - France, Germany, Italy, Spain, U.K., and Rest of Europe
• Asia-Pacific (APAC) Mass Spectrometry Market
o By technology
o By application
o By end user
o By country - China, India, Japan, South Korea, Australia, and Rest of APAC
• Latin America (LATAM) Mass Spectrometry Market
o By technology
o By application
o By end user
o By country - Brazil, Mexico, and Rest of LATAM
• Middle East and Africa (MEA) Mass Spectrometry Market
o By technology
o By application
o By end user
o By country - Saudi Arabia, South Africa, and Rest of MEA

Browse more reports:

In-Silico Drug Discovery Market - https://www.psmarketresearch.com/market-analysis/in-silico-drug-discovery-market

Proteomics Market - https://www.psmarketresearch.com/market-analysis/proteomics-market

Contact:
P&S Intelligence
Phone: +1-347-960-6455
Email: enquiry@psmarketresearch.com
Web: https://www.psmarketresearch.com
Blog: https://healthcarefuturetrends.blogspot.com

About P&S Intelligence

P&S Intelligence provides market research and consulting services to a vast array of industries across the world. As an enterprising research and consulting company, P&S believes in providing thorough insights on the ever-changing market scenario, to empower companies to make informed decisions and base their business strategies with astuteness. P&S keeps the interest of its clients at heart, which is why the insights we provide are both honest and accurate. Our long list of satisfied clients includes entry-level firms as well as multi-million-dollar businesses and government agencies.

This release was published on openPR.